Aldeyra Therapeutics, Inc.
SEC CIK 1341235 · ALDX · last insider filing 2026-06-11
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Douglas Richard | Director | filed 2016 - 2026 |
| Deptula-Hicks Darlene M | Director | filed 2026 - 2026 |
| Phillips Gary M. | Director | filed 2014 - 2026 |
| Clark William D | Director | filed 2025 - 2026 |
| Walker Neal | Director | filed 2014 - 2026 |
| Bronstein Ben | Director | filed 2014 - 2026 |
| Miller-Rich Nancy | Director | filed 2020 - 2026 |
| Brady Todd C | Director · President and CEO | filed 2014 - 2026 |
| Joyce Martin Joseph | Director | filed 2014 - 2025 |
| Treu Jesse I | Director | filed 2014 - 2020 |
| Clarke C. Boyd | Director | filed 2014 - 2016 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Alfieri Michael | Principal Financial Officer | filed 2024 - 2026 |
| Machatha Stephen | Chief Development Officer | filed 2020 - 2025 |
| Greenberg Bruce | See Remarks | filed 2022 - 2024 |
| Reed Joshua | Chief Financial Officer | filed 2018 - 2022 |
| Mcmullin David | SVP Corp. Dev. & Strategy | filed 2018 - 2020 |
| Clark David J | Chief Medical Officer | filed 2016 - 2019 |
| Tulipano Stephen J | Chief Financial Officer | filed 2014 - 2018 |
| Young Scott | Chief Operating Officer | filed 2014 - 2016 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.